Cargando…
Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19
IMPORTANCE: Type 2 diabetes (T2DM) and obesity are significant risk factors for mortality in Covid19. Metformin has sex specific immunomodulatory effects which may elucidate treatment mechanisms in COVID-19. OBJECTIVE: We sought to identify whether metformin reduced mortality from Covid19 and if sex...
Autores principales: | Bramante, Carolyn T., Ingraham, Nicholas E., Murray, Thomas A., Marmor, Schelomo, Hovertsen, Shane, Gronski, Jessica, McNeil, Chace, Feng, Ruoying, Guzman, Gabriel, Abdelwahab, Nermine, King, Samantha, Meehan, Thomas, Pendleton, Kathryn M., Benson, Bradley, Vojta, Deneen, Tignanelli, Christopher J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325185/ https://www.ncbi.nlm.nih.gov/pubmed/32607520 http://dx.doi.org/10.1101/2020.06.19.20135095 |
Ejemplares similares
-
Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
por: Bramante, Carolyn T, et al.
Publicado: (2021) -
Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit
por: Ibrahim, Sherehan, et al.
Publicado: (2021) -
Outpatient metformin use is associated with reduced severity of COVID‐19 disease in adults with overweight or obesity
por: Bramante, Carolyn T., et al.
Publicado: (2021) -
Treatment Receipt and Outcomes of Self-Reported Voice Problems in the US Population Aged ≥65 Years
por: Marmor, Schelomo, et al.
Publicado: (2018) -
We Should Do More to Offer Evidence-Based Treatment for an Important Modifiable Risk Factor for COVID-19: Obesity
por: Dutta, Nirjhar, et al.
Publicado: (2021)